A detailed history of Mengis Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 69,513 shares of PFE stock, worth $1.95 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
69,513
Previous 77,499 10.3%
Holding current value
$1.95 Million
Previous $2.17 Million 10.33%
% of portfolio
0.4%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $201,726 - $236,385
-7,986 Reduced 10.3%
69,513 $1.94 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $358,550 - $411,730
13,849 Added 21.76%
77,499 $2.15 Million
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $14,371 - $18,667
550 Added 0.87%
63,650 $1.83 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $22,495 - $26,294
-701 Reduced 1.1%
63,100 $2.09 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $28,895 - $33,432
-800 Reduced 1.24%
63,801 $2.34 Million
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $354 - $461
9 Added 0.01%
64,601 $2.64 Million
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $6,053 - $7,902
-145 Reduced 0.22%
64,592 $3.31 Million
Q3 2022

Nov 04, 2022

SELL
$43.76 - $53.42 $174,821 - $213,412
-3,995 Reduced 5.81%
64,737 $2.83 Million
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $18,425 - $21,847
-396 Reduced 0.57%
68,732 $3.6 Million
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $12,123 - $15,022
-265 Reduced 0.38%
69,128 $3.58 Million
Q4 2021

Feb 04, 2022

SELL
$41.32 - $61.25 $200,278 - $296,878
-4,847 Reduced 6.53%
69,393 $4.1 Million
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $588 - $756
15 Added 0.02%
74,240 $3.19 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $108,771 - $123,219
-3,029 Reduced 3.92%
74,225 $2.91 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $24,179 - $27,269
-722 Reduced 0.93%
77,254 $2.8 Million
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $124,976 - $158,919
3,734 Added 5.03%
77,976 $2.87 Million
Q3 2020

Oct 29, 2020

SELL
$31.75 - $37.25 $30,321 - $35,573
-955 Reduced 1.27%
74,242 $2.72 Million
Q2 2020

Jul 22, 2020

SELL
$30.12 - $36.54 $15,662 - $19,000
-520 Reduced 0.69%
75,197 $2.46 Million
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $12,001 - $17,147
-444 Reduced 0.58%
75,717 $2.47 Million
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $31,109 - $35,305
-945 Reduced 1.23%
76,161 $2.98 Million
Q3 2019

Nov 05, 2019

BUY
$32.49 - $42.13 $29,078 - $37,706
895 Added 1.17%
77,106 $2.77 Million
Q2 2019

Jul 18, 2019

BUY
$36.98 - $41.52 $1.66 Million - $1.87 Million
44,961 Added 143.88%
76,211 $3.3 Million
Q1 2019

May 06, 2019

SELL
$37.5 - $41.2 $164,850 - $181,115
-4,396 Reduced 12.33%
31,250 $1.33 Million
Q4 2018

Feb 06, 2019

SELL
$38.47 - $43.86 $188,349 - $214,738
-4,896 Reduced 12.08%
35,646 $1.56 Million
Q3 2018

Nov 05, 2018

SELL
$34.47 - $41.81 $21,991 - $26,674
-638 Reduced 1.55%
40,542 $1.79 Million
Q2 2018

Jul 24, 2018

SELL
$32.98 - $35.16 $84,923 - $90,536
-2,575 Reduced 5.89%
41,180 $1.49 Million
Q1 2018

Apr 27, 2018

BUY
$31.91 - $37.02 $127 - $148
4 Added 0.01%
43,755 $1.55 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $11,108 - $11,786
334 Added 0.77%
43,751 $1.58 Million
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $1.35 Million - $1.48 Million
43,417
43,417 $1.55 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $158B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mengis Capital Management, Inc. Portfolio

Follow Mengis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.